NEUTROPHIL–MACROPHAGE IMMUNE AXIS IN ATRIAL FIBRILLATION: ASSESSMENT OF MYELOPEROXIDASE AND GALECTIN-3 AS MARKERS OF INFLAMMATORY AND FIBROTIC REMODELING
Veredas do Direito · 21.07.2026 · 23 (12) · e237595
DOI: 10.18623/rvd.v23.7595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veredas do Direito, online erschienen am 21.07.2026. Verfasst von Tuqa M. Alasady und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is increasingly recognized as an immune-mediated disorder characterized by persistent inflammation, oxidative stress, and atrial remodeling. Myeloperoxidase (MPO) and Galectin-3 are key biomarkers involved in innate immune activation, oxidative injury, fibrosis, and structural remodeling of the atrial myocardium.
Objective
This study aimed to evaluate serum levels of MPO and Galectin-3 in patients with atrial fibrillation and to investigate their potential diagnostic value as biomarkers of immune-mediated atrial remodeling.
Methods
A cross-sectional case–control study was conducted at the Cardiac Center of Al-Sadder Teaching City, Najaf, Iraq, between November 2025 and March 2026. The study included 100 patients diagnosed with AF and 50 apparently healthy controls. Serum MPO and Galectin-3 levels were measured using enzyme-linked immunosorbent assay (ELISA). Statistical analysis and receiver operating characteristic (ROC) curve analysis were performed using SPSS version 23.
Results
Serum MPO levels were significantly higher in patients with atrial fibrillation (AF) than in controls (4.19 ± 0.77 vs. 3.48 ± 0.98 ng/mL, P = 0.001). Similarly, Galectin 3 levels were markedly elevated in the AF group (1375.55 ± 346.36 vs. 357.94 ± 94.03 pg/mL, P = 0.001).
Conclusion
The significant increase in both Galectin 3 and MPO levels in AF patients suggests that inflammatory, fibrotic, and oxidative immune pathways contribute to the pathogenesis of AF.
Zitieren
APA
Alasady, T. M., & Al-Fatlawi, N. A. G. (2026). NEUTROPHIL–MACROPHAGE IMMUNE AXIS IN ATRIAL FIBRILLATION: ASSESSMENT OF MYELOPEROXIDASE AND GALECTIN-3 AS MARKERS OF INFLAMMATORY AND FIBROTIC REMODELING. Veredas do Direito, 23(12), e237595. https://doi.org/10.18623/rvd.v23.7595
Vancouver
Alasady TM, Al-Fatlawi NAG. NEUTROPHIL–MACROPHAGE IMMUNE AXIS IN ATRIAL FIBRILLATION: ASSESSMENT OF MYELOPEROXIDASE AND GALECTIN-3 AS MARKERS OF INFLAMMATORY AND FIBROTIC REMODELING. Veredas do Direito. 2026;23(12):e237595. doi:10.18623/rvd.v23.7595
BibTeX
@article{Alasady2026,
author = {Alasady, Tuqa M. and Al-Fatlawi, Noor Alhuda Ghanem},
title = {NEUTROPHIL–MACROPHAGE IMMUNE AXIS IN ATRIAL FIBRILLATION: ASSESSMENT OF MYELOPEROXIDASE AND GALECTIN-3 AS MARKERS OF INFLAMMATORY AND FIBROTIC REMODELING},
journal = {Veredas do Direito},
year = {2026},
volume = {23},
number = {12},
pages = {e237595},
doi = {10.18623/rvd.v23.7595}
}
EUVIMED